Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: DMaA who wrote (133806)	8/22/2005 5:26:33 PM
From: carranza2	Respond to of 793717

If the equity owners get raped, capital to finance research will dry up completely. I don't know about that. Capital seeks profits and profits can be made from a company that develops and markets necessary drugs. Illnesses will be with us like death and taxes, and there will always be efforts to minimize their impact. The Merck lesson, IMO, will be that pharmaceutical companies' corporate governance will change so that problems will be identified and corrected a lot more quickly, before they become a catastrophe like Vioxx. If Merck had acted quickly instead of waiting years, I don't think it would have been hammered as badly as it was in a conservative jurisdiction.